Dose Combinations News Today : Breaking News, Live Updates &

Banned Drugs | Drugs Banned in India | List of Banned Drugs

Published: March 28, 2024

Several drugs are either banned or withdrawn after introduction in the market.

HIV Antivirals Market is forecasted to exceed US$ 47.0 Billion by 2032, fueled by new treatment opti

Published: October 18, 2023

The pharmaceutical industry’s division devoted to the development, manufacturing, and distribution of drugs used to treat HIV (Human Immunodeficiency Virus) infection is known as the HIV Antivirals Market. The main method for treating HIV is called antiretroviral therapy (ART), and it uses a variety of antiviral med...

Source: pharmiweb.com

Fixed-Combinations and Single-Entity Versions of Previously Approved Antiretrovirals for the Treatment or Prevention of Human Immunodeficiency Virus-One Under the President's Emergency Plan for Acquired Immunodeficiency Syndrome Relief

Published: August 2, 2023

Procedural

Source: fda.gov

Whale Of A Tale: Tracing The Centre's Recent Ban On 14 FDCs Approved Prior To 1988

Published: July 5, 2023

The Central Government, has recently, in exercise of its powers under Section 26-A of the Drugs and Cosmetics Act, 1940 , vide various notifications , prohibited the manufacture of 14 Fixed Dose...

Source: marketscreener.com

HIV Antivirals Market is set to reach a valuation of US$ 30.6 Billion in 2022

Published: September 9, 2022

[300 Pages Report] The global HIV antivirals market is expected to be worth $30.6 billion in 2022, with a CAGR of 4.4 percent during the forecast period (2022-2032). According to a recent study, fixed-dose combinations (FDCs) will account for more than 83 percent of the HIV antivirals market in 2021.According to Fut...